Lumida
/NUTX
⌘K
Nutex Health Inc

Nutex Health Inc

NUTX
$162.98USD-0.86%-1.42 today

MARKET CAP

1.1B

P/E (TTM)

12.5x

FWD P/E

7.7x

DAY RANGE

$158 – $168

52W RANGE

$77
$204

AI Summary

Stalk
StalkMedium

In Stage 2 advancing environment, NUTX maintains a medium-term bullish bias despite recent support failure at the $173 zone and early momentum loss. Price remains above the rising 50 DMA, anchoring upside potential, while 9/21 EMAs cap rallies, indicating caution. Short-term timing is unfavorable for entries as price trades below falling EMAs with distribution pressure evident. We recommend stalking for a disciplined re-entry into the uptrend near structural support, awaiting a clean pullback into the rising 50 DMA or reclaim of the 9/21 EMA zone to confirm resumption.

  • Q1 2025 revenue grew 214% YoY to $211.8M; adjusted EBITDA $72.8M
  • Arbitration drives 71% of hospital revenue with >85% win rate for cash predictability
  • Dependence on arbitration under IDR exposes revenue to potential regulatory reversals; $55M cut last cycle
Full analysis →
Insider Trades26 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 19, 2026BuyNUTXWarren HosseinionPresident252$94.07$1.1B-20.11%+111.09%$23.7K+1.26%Sell Now
Mar 13, 2026BuyNUTXPamela W. MontgomeryChief Legal Officer-Healthcare79$88.87$1.1B-20.11%+111.09%$7.0K+1.11%Sell Now
Mar 10, 2026SellNUTXMichael L. ChangChief Medical Officer769$86.22$1.1B-20.11%+111.09%$66.3K-0.87%Sell Now
Mar 10, 2026SellNUTXPamela W. MontgomeryChief Legal Officer-Healthcare776$86.22$1.1B-20.11%+111.09%$66.9K-8.95%Sell Now
Mar 10, 2026SellNUTXElisa V LuqmanChief Legal Officer - SEC784$86.22$1.1B-20.11%+111.09%$67.6K-10.32%Sell Now
Mar 10, 2026SellNUTXThomas T. VoChief Executive Officer3,017$86.22$1.1B-20.11%+111.09%$260.1K-0.16%Sell Now
Mar 10, 2026SellNUTXWarren HosseinionPresident3,274$86.22$1.1B-20.11%+111.09%$282.3K-12.34%Sell Now
Nov 25, 2025BuyNUTXJon Christian BatesChief Financial Officer750$136.71$1.1B-20.11%+111.09%$102.5K+15.34%Sell Now
Apr 8, 2025BuyNUTXJon Christian BatesChief Financial Officer1,000$81.81$1.1B-20.11%+111.09%$81.8K+9.63%Sell Now
Apr 4, 2025SellNUTXElisa V LuqmanChief Legal Officer - SEC266$72.10$1.1B-20.11%+111.09%$19.2K-4.20%Sell Now
Apr 4, 2025SellNUTXMichael L. ChangChief Medical Officer266$72.10$1.1B-20.11%+111.09%$19.2K-0.31%Sell Now
Apr 4, 2025SellNUTXPamela W. MontgomeryChief Legal Officer-Healthcare290$72.10$1.1B-20.11%+111.09%$20.9K-4.11%Sell Now
Apr 4, 2025SellNUTXJoshua DetillioChief Operating Officer452$72.10$1.1B-20.11%+111.09%$32.6K-2.64%Sell Now
Apr 4, 2025SellNUTXThomas T. VoChief Executive Officer895$72.10$1.1B-20.11%+111.09%$64.5K-0.05%Sell Now
Apr 4, 2025SellNUTXWarren HosseinionPresident1,072$72.10$1.1B-20.11%+111.09%$77.3K-5.47%Sell Now
Jan 8, 2025BuyNUTXThomas T. VoChief Executive Officer5,000$31.69$1.1B-20.11%+111.09%$158.4K+0.27%Sell Now
Sep 6, 2024BuyNUTXTimur DoganChief Technology Officer68,965$0.29$1.1B-20.11%+111.09%$20.0K+53.73%Sell Now
Sep 6, 2024BuyNUTXMeeshanthini DoganChief Executive Officer68,965$0.29$1.1B-20.11%+111.09%$20.0K+4.35%Sell Now
Aug 22, 2024BuyNUTXJon Christian BatesChief Financial Officer1,350$21.46$1.1B-20.11%+111.09%$29.0K+145.63%Sell Now
Aug 19, 2024BuyNUTXJoshua DetillioChief Operating Officer1,875$17.71$1.1B-20.11%+111.09%$33.2K+26.17%Sell Now
Jun 12, 2024BuyNUTXJoshua DetillioChief Operating Officer20,000$0.54$1.1B-20.11%+111.09%$10.8K+214.29%Sell Now
May 13, 2024BuyNUTXThomas T. VoChief Executive Officer72,478$0.69$1.1B-20.11%+111.09%$50.4K+0.10%Sell Now
Nov 17, 2023BuyNUTXThomas T. VoChief Executive Officer500,000$0.23$1.1B-20.11%+111.09%$113.9K+0.09%Sell Now
Nov 15, 2023BuyNUTXJoshua DetillioChief Operating Officer140,000$0.24$1.1B-20.11%+111.09%$34.2KSell Now
Sep 22, 2023SellNUTXWarren HosseinionPresident141,000$29.82$1.1B-20.11%+111.09%$4.2M-7.54%Sell Now
Aug 28, 2023BuyNUTXThomas T. VoChief Executive Officer1,000,000$0.30$1.1B-20.11%+111.09%$296.0K+0.09%Sell Now